|
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
|
5R01CA101700-08
|
$358,748
|
GLICKSON, JERRY
|
UNIVERSITY OF PENNSYLVANIA
|
|
A bifunctional nanomedicine for both specific imaging and targeting therapy of an
|
5R01CA151955-03
|
$309,964
|
ZU, YOULI
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$354,811
|
Rothman, Nat
|
DCEG (NCI)
|
|
A Fourth Outcome: DNA Damage and the Differentiation of B Cells
|
5R01CA156674-02
|
$314,884
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera
|
5R01CA139119-03
|
$260,852
|
Chaudhary, Preet
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Highly Multiplexed PCR Platform for Gene Expression Profiling from FFPE Tissue
|
1R33CA160011-01A1
|
$335,186
|
Nolling, Jork
|
PRIMERADX, INC.
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIABC011064
|
$151,742
|
Mock, Beverly
|
CCR (NCI)
|
|
A multi-center international hospital-based case-control study of lymphoma in Asia (AsiaLymph)
|
ZIA CP010136-10512
|
$1,810,434
|
Lan, Qing
|
DCEG (NCI)
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
5U54CA155496-02
|
$1,712,824
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A novel enzymatic activity of WSTF and its role in tumorigenesis
|
5R00CA131560-05
|
$241,530
|
Xiao, zhuo
|
YALE UNIVERSITY
|
|
A Phase I trial combining fenretinide and safingol to target overproduction of di
|
5R21CA161889-02
|
$311,717
|
REYNOLDS, CHARLES
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma
|
5R01CA149445-02
|
$549,324
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIASC010356
|
$343,957
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic Training in Medical Oncology
|
3T32CA009297-29S1
|
$68,072
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Academic Training in Medical Oncology
|
5T32CA009297-29
|
$322,328
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Activation of BCL-2 in Hematologic Malignancies
|
5R01CA056764-18
|
$281,785
|
BOXER, LINDA
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
|
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
|
5R01CA136470-04
|
$318,518
|
SLECKMAN, BARRY
|
WASHINGTON UNIVERSITY
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIASC010378
|
$441,016
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
2P01CA018029-37A1
|
$4,225,448
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
5U01CA096230-10
|
$832,033
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-05S1
|
$450,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-06
|
$6,010,333
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIABC011415
|
$30,333
|
Kochenderfer, James
|
CCR (NCI)
|
|
Allotransplant for DOCK8 deficiency
|
ZIABC011374
|
$163,456
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma
|
5R21CA162277-02
|
$163,125
|
Webb, Tonya
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression
|
5R01CA130752-05
|
$299,900
|
FLEMINGTON, ERIK
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-10
|
$330,583
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Anatomic Pathology Residency Program
|
ZIEBC011384
|
$1,082,541
|
Oberholtzer, John
|
CCR (NCI)
|
|
Animal Model and Genotyping Core Support Facility
|
ZICBC011047
|
$1,205,211
|
DuBois, Wendy
|
CCR (NCI)
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-06A1
|
$7,500
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Anti-viral DC/NK interactions
|
5R01CA108609-09
|
$176,961
|
MUNZ, CHRISTIAN
|
UNIVERSITY OF ZURICH
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
ZIABC010647
|
$297,122
|
Rader, Christoph
|
CCR (NCI)
|
|
Antibody-CpG conjugates for the treatment of B cell lymphoma
|
5R01CA149254-03
|
$309,964
|
Timmerman, John
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Antibody-interferon fusion proteins for treatment of B-cell malignancies
|
5R01CA162964-02
|
$319,550
|
MORRISON, SHERIE
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Antibody-mediated Gene Therapy for the Treatment of Cancer
|
5K01CA138559-04
|
$142,677
|
Daniels, Tracy
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Anticancer drug-induced BH3-only protein.Bak interactions
|
1R01CA166741-01
|
$332,564
|
KAUFMANN, SCOTT
|
MAYO CLINIC
|
|
Approaches to discover and quantify apoptotic biomarkers for cancer treatment
|
5R01CA154802-02
|
$320,588
|
WELLS, JAMES
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIABC011413
|
$60,665
|
Kochenderfer, James
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
Custer, Mary
|
CCR (NCI)
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
5R01CA077429-13
|
$410,451
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-13
|
$284,448
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|